Chintal Shah

Dr Chintal Shah is a trained health economist and pharmacoepidemiologist, and is currently a senior scientist in the Oncology Outcomes Research unit at AstraZeneca Pharmaceuticals. He received his pharmacy degree from University of Mumbai (2016), his M.S. in Pharmaceutical Outcomes and Policy from University of Florida (2018) and PhD in Pharmaceutical Health Services Research from University of Maryland Baltimore (2023). During his PhD he was also the Rare Disease fellow in the Value and Evidence Generation team at Takeda Pharmaceuticals.